Laura Dhariwal, MD
NPI 1699119198 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · New York, NY
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Laura Dhariwal, MD is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider in New York, NY (NPI 1699119198).
Provider details
- NPI number
- 1699119198
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 25MA10103600 (NJ)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense 307548 (NY)
Allopathic & Osteopathic Physicians
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician207VF0040XLicense 25MA10103600 (NJ)
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
13 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
756 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Simple Insertion of Temporary Bladder Tube51702 | 195 | $70 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 134 | $140 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 110 | $182 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 84 | $100 |
| Insertion of Temporary Bladder Tube51701 | 76 | $49 |
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 268 | 173 |
| Vibegronbrand: Gemtesa | 74 | 19 |
| Mirabegronbrand: Myrbetriq | 49 | 28 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 38 | 34 |
| Onabotulinumtoxinabrand: Botox | 11 | 11 |
| Estrogens, Conjugatedbrand: Premarin | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$417 across 9 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-04-26
- Last updated
- 2025-04-17
- Certified
- 2025-04-17
Frequently asked questions
- What is Laura Dhariwal's NPI number?
- Laura Dhariwal's National Provider Identifier (NPI) is 1699119198, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Laura Dhariwal's specialty?
- Laura Dhariwal is listed in the NPPES registry with a primary specialty of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (Allopathic & Osteopathic Physicians).
- Where is Laura Dhariwal located?
- Laura Dhariwal's practice location on file with NPPES is 161 Fort Washington Ave, New York, NY 10032-3729.
- What is Laura Dhariwal's phone number?
- The practice phone number listed in the NPPES registry for Laura Dhariwal is (516) 562-0100.
- Does Laura Dhariwal accept Medicare?
- Laura Dhariwal is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Laura Dhariwal's NPI active?
- Yes — Laura Dhariwal's NPI (1699119198) is active in the NPPES registry as of the last update on 2025-04-17.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.